Why PsyBio Will be the Leader in the Psychedelic Drug Discovery Industry

1_2x.png

PsyBio has compiled an ever-expanding portfolio of over 80 molecules, utilizing scientific methodology to prioritize ongoing development

2_2x.png

PsyBio is an industry-first and leader in developing cheaper, faster, and greener
psychedelic inspired compound discovery and production

3_2x.png

PsyBio has contracted with three globally acclaimed and experienced contract
manufacturing organizations for process development and commercialization of lead
compounds

band _edited.png

PsyBio is one of a small number of companies actively working towards US FDA sanctioned clinical trials in the psychedelic inspired biotherapeutic space

Molecular development Pipeline